Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy

References

• Alam MI, Baboota S, Ahuja A, et al. (2013). Intranasal infusion of nanostructured lipid carriers (NLC) containing CNS acting drug and estimation in brain and blood. Drug Deliv 20:247–51
   PubMed Web of Science ®Google Scholar
• Bernal GM, LaRiviere MJ, Mansour N, et al. (2014). Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine 10:149–57
   PubMed Web of Science ®Google Scholar
• Bothun GD, Lelis A, Chen Y, et al. (2011). Multicomponent folate-targeted magnetoliposomes: design, characterization, and cellular uptake. Nanomedicine 7:797–805
   PubMed Web of Science ®Google Scholar
• Buie LW, Valgus JM. (2012). Current treatment options for the management of glioblastoma multiforme. Hematol Oncol Pharm 2:57–63
   Google Scholar
• Casagrande N, De Paoli M, Celegato M, et al. (2013). Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer. Gynecol Oncol 131:744–52
   PubMed Web of Science ®Google Scholar
• Cavanagh TT, Holle LM. (2014). Potential new gene therapy option with sitimagene ceradenovec for newly diagnosed patients with glioblastoma multiforme. Cancer Biol Ther 15:263–5
   PubMed Web of Science ®Google Scholar
• Choi YH. (2014). Linoleic acid-induced growth inhibition of human gastric epithelial adenocarcinoma AGS cells is associated with down-regulation of prostaglandin E2 synthesis and telomerase activity. J Cancer Prev 19:31–8
   PubMedGoogle Scholar
• Esposito E, Boschi A, Ravani L, et al. (2015). Biodistribution of nanostructured lipid carriers: a tomographic study. Eur J Pharm Biopharm 89:145–56
   PubMed Web of Science ®Google Scholar
• Fathi-Azarbayjani A, Ng KX, Chan YW, Chan SY. (2015). Lipid vesicles for the skin delivery of diclofenac: cerosomes vs. other lipid suspensions. Adv Pharm Bull 5:25–33
   PubMed Web of Science ®Google Scholar
• Gao H, Xiong Y, Zhang S, et al. (2014a). RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration. Mol Pharm 11:1042–52
   PubMed Web of Science ®Google Scholar
• Gao H, Yang Z, Cao S, et al. (2014b). Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment. Biomaterials 35:374–82
   Web of Science ®Google Scholar
• Kesari S. (2011). Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments. Semin Oncol 38:S2–10
   PubMed Web of Science ®Google Scholar
• Luan J, Zhang D, Hao L, et al. (2013). Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release. Drug Deliv 20:324–30
   PubMed Web of Science ®Google Scholar
• Lv S, Tang Z, Li M, et al. (2014). Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer. Biomaterials 35:6118–29
   PubMed Web of Science ®Google Scholar
• Mattingly SJ, O'Toole MG, James KT, et al. (2015). Magnetic nanoparticle-supported lipid bilayers for drug delivery. Langmuir 31:3326–32
   PubMed Web of Science ®Google Scholar
• Miura Y, Takenaka T, Toh K, et al. (2013). Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier. ACS Nano 7:8583–92
   PubMed Web of Science ®Google Scholar
• Sarisozen C, Abouzeid AH, Torchilin VP. (2014). The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors. Eur J Pharm Biopharm 88:539–50
   PubMed Web of Science ®Google Scholar
• Shidhaye SS, Vaidya R, Sutar S, et al. (2008). Solid lipid nanoparticles and nanostructured lipid carriers – innovative generations of solid lipid carriers. Curr Drug Deliv 5:324–31
   PubMedGoogle Scholar
• Tiwari R, Pathak K. (2011). Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm 415:232–43
   PubMed Web of Science ®Google Scholar
• Wang Q, Cheng H, Zhou K, et al. (2013). Nanostructured lipid carriers as a delivery system of biochanin A. Drug Deliv 20:331–7
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. (2004). Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56:1257–72
   PubMed Web of Science ®Google Scholar
• Xiao H, Song H, Yang Q, et al. (2012). A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance. Biomaterials 33:6507–19
   PubMed Web of Science ®Google Scholar
• Yu W, Liu C, Liu Y, et al. (2010). Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res 27:1584–96
   PubMed Web of Science ®Google Scholar
• Zeng S, Wu F, Li B, et al. (2014). Synthesis, characterization, and evaluation of a novel amphiphilic polymer RGD-PEG-Chol for target drug delivery system. Sci World J 2014:546176
   Google Scholar